Absorption, distribution, excretion and metabolism of tiaramide hydrochloride: a new anti-inflammatory drug
Noda, K.; Noguchi, H.; Okui, M.; Tada, K.; Morimoto, Y.
Arzneimittel-Forschung 22(4): 732-743
1972
ISSN/ISBN: 0004-4172 PMID: 4626080 Document Number: 45464
Document emailed within 1 workday
Related Documents
Goldaniga, G.C.; Pianezzola, E.; Valzelli, G. 1974: Absorption, excretion and metabolism of a new analgesic and anti-inflammatory drug K 4277 in rats, guinea pigs, rabbits and dogs Arzneimittel-Forschung 24(10): 1603-1606Goto, S. 1974: Drug interaction observed in absorption, distribution, metabolism and excretion processes Rinsho Byori. Japanese Journal of Clinical Pathology 22(Suppl): 297-309
Hashimoto, M.; Miyazaki, H.; Fujii, T.; Nambu, K.; Tanaka, K. 1979: Studies on disposition and metabolism of tolmetin, a new anti-inflammatory agent, in rats and mice. I. Absorption, distribution, and excrection of [14C]tolmetin radioactivity Drug Metabolism and Disposition: the Biological Fate of Chemicals 7(1): 14-19
Ohtsuki, T.; Takaichi, M.; Jin, Y.; Yokoshima, T.; Kato, R. 1984: Absorption, distribution, excretion and metabolism of domiodol Il Farmaco; Edizione Pratica 39(9): 291-309
Elliott, H.L.; Meredith, P.A. 1991: The clinical consequences of the absorption, distribution, metabolism and excretion of amlodipine Postgraduate Medical Journal 67(Suppl 3): S20-S23
Musa, M.N.; Lower, G.M.; Welling, P.G.; Johnson, B.M.; Kaiman, B.D.; Bryan, G.T. 1974: Absorption, tissue distribution, and excretion of the anti-neoplastic agent guanazole in the rat Research Communications in Chemical Pathology and Pharmacology 7(3): 497-512
Gerlóczy, A.; Fónagy, A.; Keresztes, P.; Perlaky, L.; Szejtli, J. 1985: Absorption, distribution, excretion and metabolism of orally administered 14C-beta-cyclodextrin in rat Arzneimittel-Forschung 35(7): 1042-1047
Nakazawa, S.; Sato, H.; Watanabe, O.; Sadaoka, K.; Fujii, N. 1973: Absorption, excretion, distribution and metabolism of 3',4'-dideoxykanamycin B. 4. Pharmacokinetic analysis in pediatrics Japanese Journal of Antibiotics 26(5): 454-458
Fujii, T.; Matsumoto, S.; Amejima, H.; Hatoyama, T.; Nakao, M.; Kagemoto, A.; Tanaka, K.; Miyazaki, H. 1994: Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats Arzneimittel-Forschung 44(4): 527-538
Matsuda, H.; Kawaba, T.; Yamamoto, Y.; Ogawa, S. 1976: Absorption, distribution, excretion and metabolism of a basic ether compound (R97) with antispasmodic activity Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 72(6): 657-672
Sakai, A.; Iwasaki, M.; Suzuki, T.; Morishita, M.; Muranishi, S. 1988: Studies on the metabolic fate of 14C-rokitamycin. Absorption, distribution, metabolism and excretion in infant rats Japanese Journal of Antibiotics 41(7): 797-808
Suzuki, T.; Serizawa, K.; Somiya, Y.; Shirai, M.; Endo, S.; Morishita, M. 1987: Studies on the metabolic fate of isepamicin sulfate (HAPA-B). I. Absorption, distribution, metabolism and excretion in rats Japanese Journal of Antibiotics 40(1): 188-201
Uda, F.; Ohashi, H.; Tokiwa, T. 1982: Absorption, distribution, metabolism and excretion of netilmicin in rats (I). Metabolic fate of netilmicin after a single dose Japanese Journal of Antibiotics 35(4): 950-959
Nowicka, A.; Prussak, T.; Szukalski, B. 1975: Metabolism of some ethylenediamine derivatives with antiarrhythmic properties. I. Absorption, distribution in tissues and excretion of 14-C labelled N, N'-bis-[3-(p-methoxyphenoxy)-2-hydroxypropyl]-ethylenediamine dimethanesulphonate (MK-142) in rats Polish Journal of Pharmacology and Pharmacy 27(2): 113-120
Scatina, J.A.; Wells, D.S.; Kimmel, H.B.; Kemper, C.J.; Sisenwine, S.F. 1990: Excretion and metabolism of recainam, a new anti-arrhythmic drug, in laboratory animals and humans Drug Metabolism and Disposition: the Biological Fate of Chemicals 18(5): 746-752
Nakamura, H.; Kadokawa, T.; Nakatsuji, K.; Nakamura, K. 1970: Pharmacological studies of a new anti-inflammatory drug, 1-phenylsulfonyl-5,5-diphenylhydantoin (PC-796) in experimental animals. I. Anti-inflammatory, analgesic and anti-pyretic activity Arzneimittel-Forschung 20(8): 1032-1046
Brett, G.M.; Hollands, W.; Needs, P.W.; Teucher, B.; Dainty, J.R.; Davis, B.D.; Brodbelt, J.S.; Kroon, P.A. 2009: Absorption, metabolism and excretion of flavanones from single portions of orange fruit and juice and effects of anthropometric variables and contraceptive pill use on flavanone excretion British Journal of Nutrition 101(5): 664-675
Heykants, J.J.; Meuldermans, W.E.; Michiels, L.J.; Lewi, P.J.; Janssen, P.A. 1975: Distribution, metabolism and excretion of etomidate, a short-acting hypnotic drug, in the rat. Comparative study of (R)-(+)-(--)-Etomidate Archives Internationales de Pharmacodynamie et de Therapie 216(1): 113-129
Fujita, M.; Tomo, N.; Abe, M.; Hosoi, K.; Sató, T. 1975: Experimental studies on absorption, distribution and excretion of a new antibiotic, fosfomycin. II. Absorption of oral preparations of fosfomycin calcium salt in dogs Japanese Journal of Antibiotics 28(3): 314-319
Veis, R.A.; Semenov, S.M. 1964: Apropos of the Absorption, Distribution and Excretion of Nobobiocin Antibiotiki 9: 821-824